Company
Investment-firm
Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Foundation Medicine New Zealand
Roche Foundation Medicine is a collaboration that aims to advance precision medicine for cancer patients globally.
Sector
Subsector
Location
Kuveda
Kuveda provides oncologists with SaaS-based tools and services for the analysis of cancer patients’ molecular profiles.
Sector
Subsector
Keywords
Location
total rounds
KPS Life Sciences
KPS provides molecular information and diagnostic services for personalized cancer therapies globally.
Sector
Subsector
Keywords
Location
Molecular Match
Molecular Match is a health and wellness company that uses proprietary algorithms to match cancer patients with appropriate therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds4
Investments2
Moffitt Cancer Center
Moffitt Cancer Center is a nonprofit cancer treatment and research center.
Sector
Subsector
Location
total rounds
total raised
COTA Healthcare
COTA brings clarity to cancer, ensuring a clear path to the right care for everyone affected by the disease.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Investors9
Number of lead investors
Number of investors
GV
GV is a venture capital firm that provides funding to innovative startups in various fields.
Sector
Subsector
Location
count Of Investments
count Of Exists
Krishna Yeshwant
Dr. Krishna Yeshwant is a physician, programmer, and entrepreneur who has been working with GV since its inception. He first joined Google as part of the New Business Development team. Prior to Google he helped start an electronic data interchange company that was acquired by Hewlett-Packard and a network security company that was acquired by Symantec. He also co-authored the business plan for Diagnostics For All, which won both the Harvard Business School and MIT $100k business plan competitions. Previously, Krishna published several book chapters and journal articles in the field of computer-guided surgery, completed research in tissue engineering, and developed and licensed multiple surgical devices. He has worked with the technology transfer offices of MIT, Harvard, and Massachusetts General Hospital. Krishna has a B.S. in computer science from Stanford University. He also earned an M.D. from Harvard Medical School, an MBA from Harvard Business School, and completed his residency at Brigham and Women’s Hospital in Boston, MA where he continues to practice.
current job
Redmile Group
Redmile Group is a San Francisco-based healthcare investment company.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Roche Venture Fund
Roche Venture Fund invests in and developing innovative life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Acquisitions1
Lexent Bio acquired by Foundation Medicine
acquirer
date
type
Lexent Bio
Lexent Bio is revolutionizing cancer diagnosis and treatment with its liquid biopsy technology.
Sector
Subsector
Keywords
Location
total rounds
People
Founders1
Alexis Borisy
Alexis Borisy is the Chairman of the Board of Directors & Co - Founder of Foundation Medicine Inc.He is also a Partner at Third Rock Ventures.Alexis Borisy is a successful biotechnology entrepreneur with 20 years of experience building and operating innovative science-based organizations. Alexis Borisy joined the life sciences venture capital firm Third Rock Ventures in 2009 to focus on the formation, development and strategy of new companies. He co-founded Foundation Medicine and served as the company’s interim CEO through May 2011.Prior to joining Third Rock Ventures, Alexis Borisy founded CombinatoRx in 2000, serving as its Chief Executive Officer and bringing the company public on the NASDAQ. He has raised $750 million in financing and business development deals, and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard where he was a Howard Hughes Predoctoral Fellow, Alexis Borisy was honored as the Massachusetts Institute of Technology’s Technology Review Innovator of the Year. He was also chosen as the New England Entrepreneur of the Year in Life Sciences and was honored as a Presidential Scholar.Alexis Borisy’s Undergraduate Degree in Chemistry is from the University of Chicago, and he did his graduate work in the laboratory of Dr. Stuart Schreiber at Harvard University. Alexis Borisy serves on the Board of the Biotechnology Industry Organization, is an Overseer at the Boston Museum of Science, is the Chairman of Forma Therapeutics, and serves on the board of Blueprint Medicines.
current job
organization founded
Alexis Borisy
Employee Profiles302
Meagan Montesion
Senior scientist, cancer genomics research
Daniel Gerow
Senior director cloud platform engineering
Activity
Recent News14
The graph reveals the ratio (%) of positive news articles in a chosen time range